In vivo and in vitro bioconversion of epsilon-rhodomycinone glycoside to doxorubicin: functions of DauP, DauK, and DoxA
about
Purification, properties, and characterization of recombinant Streptomyces sp. strain C5 DoxA, a cytochrome P-450 catalyzing multiple steps in doxorubicin biosynthesisDoxorubicin overproduction in Streptomyces peucetius: cloning and characterization of the dnrU ketoreductase and dnrV genes and the doxA cytochrome P-450 hydroxylase gene.Crystal structure of aclacinomycin methylesterase with bound product analogues: implications for anthracycline recognition and mechanismTirandamycin biosynthesis is mediated by co-dependent oxidative enzymesCrystal structure of a ternary complex of DnrK, a methyltransferase in daunorubicin biosynthesis, with bound productsStructure of the polyketide cyclase SnoaL reveals a novel mechanism for enzymatic aldol condensation.The plmS2-encoded cytochrome P450 monooxygenase mediates hydroxylation of phoslactomycin B in Streptomyces sp. strain HK803.Isolation, characterization, and heterologous expression of the biosynthesis gene cluster for the antitumor anthracycline steffimycinDivergent evolution of an atypical S-adenosyl-l-methionine-dependent monooxygenase involved in anthracycline biosynthesis.Exploiting Streptomyces coelicolor A3(2) P450s as a model for application in drug discovery.Biotechnological doxorubicin production: pathway and regulation engineering of strains for enhanced production.Hutchinson's legacy: keeping on polyketide biosynthesis.Regulation of daunorubicin biosynthesis in Streptomyces peucetius - feed forward and feedback transcriptional control.Cytochromes P450 for natural product biosynthesis in Streptomyces: sequence, structure, and function.Functional AdoMet Isosteres Resistant to Classical AdoMet Degradation Pathways.Functional characterization of O-methyltransferases used to catalyse site-specific methylation in the post-tailoring steps of pradimicin biosynthesis.
P2860
Q24516813-DDC762D1-A579-4A08-8DE8-619EA394FC82Q24516817-F2F3D709-EA8A-49B3-8555-72E223EAAE5FQ27641730-95288782-55E9-4ABD-B28F-F25745262518Q27670937-B0E4B09A-B997-41AD-803C-54E68EB8BD7AQ28273696-4EF0C5A3-5F55-4EF8-8C4C-4A3723CC149AQ30164179-5A6734A2-8341-43B8-96D5-87F9F2250BD3Q34150930-BBFFC865-5E8B-4055-B4B4-ECED15DA1CE7Q34720902-61B69022-A443-4103-A6AC-72E008D7CC27Q35961223-104DB1D6-22DA-47C8-A4F2-C640F43F4F77Q36545019-F28ED931-4FA1-4B81-A7B7-D806682B0CE7Q37761315-B24D87F9-C9EB-44AA-AD20-0E3B146FCA11Q37808352-02F56C12-F541-48E6-8E99-D8174E00B4FAQ38082411-9BEA671F-978C-4011-9F16-68ED4A617094Q38429569-DB5CDCCD-2DA8-466F-81AF-F11F313C30D7Q41112322-1632712A-4018-4B4B-977B-9C88376D4D59Q47408710-B071EBE8-A22C-490F-87ED-8AF710FC3506
P2860
In vivo and in vitro bioconversion of epsilon-rhodomycinone glycoside to doxorubicin: functions of DauP, DauK, and DoxA
description
1997 nî lūn-bûn
@nan
1997 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
In vivo and in vitro bioconver ...... ctions of DauP, DauK, and DoxA
@ast
In vivo and in vitro bioconver ...... ctions of DauP, DauK, and DoxA
@en
In vivo and in vitro bioconver ...... ctions of DauP, DauK, and DoxA
@nl
type
label
In vivo and in vitro bioconver ...... ctions of DauP, DauK, and DoxA
@ast
In vivo and in vitro bioconver ...... ctions of DauP, DauK, and DoxA
@en
In vivo and in vitro bioconver ...... ctions of DauP, DauK, and DoxA
@nl
prefLabel
In vivo and in vitro bioconver ...... ctions of DauP, DauK, and DoxA
@ast
In vivo and in vitro bioconver ...... ctions of DauP, DauK, and DoxA
@en
In vivo and in vitro bioconver ...... ctions of DauP, DauK, and DoxA
@nl
P2093
P2860
P921
P1476
In vivo and in vitro bioconver ...... ctions of DauP, DauK, and DoxA
@en
P2093
M L Dickens
N D Priestley
W R Strohl
P2860
P304
P356
10.1128/JB.179.8.2641-2650.1997
P407
P577
1997-04-01T00:00:00Z